Irvine-based medical device company Rebound Therapeutics Corp. raised $16.5 million in Series B financing. The financing was led by HBM-MedFocus in Irvine, Inus Opportunities Fund in New York and Wexford Capital LP in Greenwich, Conn.
Rebound was founded in 2015 and develops single-use, disposable “imaging and illumination technologies” used in surgical procedures, said Chief Executive Jeffrey Valko in a press release.
